Guard your master: Thyroid hormone receptors protect their gland of origin from thyroid cancer

Endocrinology

Volumn 145, Issue 10, 2004, Pages 4427-4429

  Köhrle, Josef ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; GROWTH FACTOR RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN G; PROTEIN P53; THYROID HORMONE RECEPTOR BETA; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR PAX8;

ANAPLASTIC CARCINOMA; CANCER CONTROL; FOLLICULAR CARCINOMA; GENE EXPRESSION; GENETIC MANIPULATION; HORMONAL CARCINOGENESIS; HUMAN; IODINE DEFICIENCY; KNOCKOUT MOUSE; LONG TERM EXPOSURE; MEDULLARY CARCINOMA; MOLONEY MURINE SARCOMA ONCOVIRUS; NONHUMAN; ONCOGENE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SHORT SURVEY; THYROID ADENOMA; THYROID CANCER; THYROID HORMONE RESISTANCE; TUMOR SUPPRESSOR GENE;

ANIMALS; GENES, TUMOR SUPPRESSOR; HUMANS; RECEPTORS, THYROID HORMONE; THYROID GLAND; THYROID HORMONE RECEPTORS BETA; THYROID NEOPLASMS;

EID: 4644301357     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0928     Document Type: Short Survey

References (31)

1. Farahati J, Geling M, Mader U, Mortl M, Luster M, Muller JG, Flentje M, Reiners C 2004 Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995. Thyroid 14:141-147
2. Robbins J 1997 Lessons from Chernobyl: the event, the aftermath fallout: radioactive, political, social. Thyroid 7:189-192
3. Williams D 2002 Cancer after nuclear fallout: lessons from the Chernobyl accident. Nat Rev Cancer 2:543-549
4. Sherman SI 2003 Thyroid carcinoma. Lancet 361:501-511
5. Piersanti M, Ezzat S, Asa SL 2003 Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol 14:183-191
6. Takami H 2003 Medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocr Pathol 14:123-131
7. Kato Y, Ying H, Willingham MC, Cheng S-Y 2004 A tumor suppressor role for thyroid hormone β receptor in a mouse model of thyroid carcinogenesis. Endocrinology 145:4430-4438
8. Cheng SY 2003 Thyroid hormone receptor mutations in cancer. Mol Cell Endocrinol 213:23-30
9. Gonzalez-Sancho JM, Garcia V, Bonilla F, Munoz A 2003 Thyroid hormone receptors/THR genes in human cancer. Cancer Lett 192:121-132
10. Suzuki H, Willingham MC, Cheng SY 2002 Mice with a mutation in the thyroid hormone receptor β gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12:963-969
11. Ying H, Suzuki H, Zhao L, Willingham MC, Meltzer P, Cheng SY 2003 Mutant thyroid hormone receptor β represses the expression and transcriptional activity of peroxisome proliferator-activated receptor γ during thyroid carcinogenesis. Cancer Res 63:5274-5280
12. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho J-Y, Xing S, Ledent C 1996 Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137:375-378
13. Vasko V, Ferrand M, Di Cristofaro J, Carayon P, Henry JF, De Micco C 2003 Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab 88:2745-2752
14. Deleu S, Allory Y, Radulescu A, Pirson I, Carrasco N, Corvilain B, Salmon I, Franc B, Dumont JE, Van Sande J, Maenhaut C 2000 Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology. Thyroid 10:131-140
15. Wynford-Thomas D 1997 Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. Horm Res 47:145-157
16. Shahedian B, Shi Y, Zou M, Farid NR 2001 Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations. Mol Genet Metab 72: 155-163
17. Goffard JC, Jin L, Mircescu H, Van Hummelen P, Ledent C, Dumont JE, Corvilain B 2004 Gene expression profile in thyroid of transgenic mice overexpressing the adenosine receptor 2a. Mol Endocrinol 18:194-213
18. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma. Science [Erratum (2000) 289:1474] 289:1357-1360
19. Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J 2002 Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metabol 87:1120-1128
20. Kamiya Y, Puzianowska-Kuznicka M, McPhie P, Nauman J, Cheng SY, Nauman A 2002 Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis 23:25-33
21. Köhrle J 2000 The deiodinase family - selenoenzymes regulating thyroid hormone availability and action. Cell Mol Life Sci 57:1853-1863
22. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128-40135
23. Köhrle J 1997 Thyroid carcinoma: interrelationships between local thyroid hormone metabolism by the type I5′-deiodinase and the expression of thyroid hormone receptors and other thyroid specific (de-)differentiation markers. In: Schmid KW, Böcker W, eds. Current topics in pathology. Berlin: Springer Verlag; 83-116
24. Lemaire M, Bayens W, de Saint-Georges L, Baugnet-Mahieu L 1981 Thyroid hormone influence on the growth of hepatoma HW-165 in Wistar rats. Biomedicine 34:133-139
25. Leuthauser SWC, Guernsey DL 1987 Thyroid hormone affects the expression of neoplastic transformation induced by DNA-transfection. Cancer Lett 35:321-326
26. Schmutzler C, Brtko J, Winzer R, Jakobs TC, Meissner-Weigl J, Simon D, Goretzki PE, Köhrle J 1998 Functional retinoid and thyroid hormone receptors in human thyroid carcinoma cell lines and tissues. Int J Cancer 76:368-376
27. Haugen BR, Larson LL, Pugazhenthi U, Hays WR, Klopper JP, Kramer CA, Sharma V 2004 Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids. J Clin Endocrinol Metab 89:272-280
28. Tang W, Nakamura Y, Zuo H, Yasuoka H, Yang Q, Wang X, Nakamura M, Mori I, Miyauchi A, Kakudo K 2003 Differentiation, proliferation and retinoid receptor status of papillary carcinoma of the thyroid. Parhol Int 53:204-213
29. Miller LD, McPhie P, Suzuki H, Kato Y, Liu ET, Cheng SY 2004 Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance. Genome Biol 5:R31
30. Nishiyama K, Baba S, Yamada T, Matsushita A, Natsume H, Nakano K, Sasaki S, Nakamura H 2003 Embryonic lethal effect of expressing a dominant negative mutant human thyroid hormone receptor α1 in mice. Endocr J 50:561-570
31. Puxeddu E, Moretti S, Elisei R, Romei C, Pascucci R, Martinelli M, Marino C, Avenia N, Rossi ED, Fadda G, Cavaliere A, Ribacchi R, Falorni A, Pontecorvi A, Pacini F, Pinchera A, Santeusanio F 2004 BRAFV599E mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab 89:2414-2420